Mesoblast (MESO) Gains from Investment Securities (2017 - 2022)
Historic Gains from Investment Securities for Mesoblast (MESO) over the last 9 years, with Q4 2024 value amounting to $4.3 million.
- Mesoblast's Gains from Investment Securities rose 9514.74% to $4.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$8.7 million, marking a year-over-year decrease of 49256.24%. This contributed to the annual value of $337000.0 for FY2024, which is 10562.7% up from last year.
- As of Q4 2024, Mesoblast's Gains from Investment Securities stood at $4.3 million, which was up 9514.74% from $337000.0 recorded in Q2 2024.
- Over the past 5 years, Mesoblast's Gains from Investment Securities peaked at $15.1 million during Q3 2020, and registered a low of -$15.1 million during Q2 2021.
- For the 5-year period, Mesoblast's Gains from Investment Securities averaged around -$791176.5, with its median value being -$280000.0 (2021).
- Its Gains from Investment Securities has fluctuated over the past 5 years, first soared by 534548.61% in 2020, then plummeted by 149571.43% in 2022.
- Quarter analysis of 5 years shows Mesoblast's Gains from Investment Securities stood at $1.5 million in 2020, then crashed by 136.11% to -$528000.0 in 2021, then plummeted by 1016.67% to -$5.9 million in 2022, then surged by 137.4% to $2.2 million in 2023, then skyrocketed by 95.15% to $4.3 million in 2024.
- Its Gains from Investment Securities stands at $4.3 million for Q4 2024, versus $337000.0 for Q2 2024 and $2.2 million for Q4 2023.